- Home
- GENI vs RLAY Comparison
GENI vs RLAY Comparison
Compare GENI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENI | RLAY |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GENI | RLAY |
|---|---|---|
| Price | $4.44 | $12.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 7 |
| Target Price | $13.06 | ★ $16.86 |
| AVG Volume (30 Days) | ★ 6.0M | 2.7M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $23.42 | N/A |
| Revenue Next Year | $20.56 | $324.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $4.19 | $1.82 |
| 52 Week High | $13.73 | $13.04 |
Technical Indicators
Market Signals| Indicator | GENI | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 33.23 | 70.59 |
| Support Level | N/A | $9.16 |
| Resistance Level | $6.75 | N/A |
| Average True Range (ATR) | 0.24 | 0.76 |
| MACD | 0.08 | 0.21 |
| Stochastic Oscillator | 21.61 | 76.18 |
Price Performance
Historical ComparisonAbout GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).